Ascend Wellness Holdings, Inc. (CSE:AAWH.U)
Canada · Delayed Price · Currency is CAD · Price in USD 0.4800
-0.0100 (-2.04%)
At close: Mar 20, 2026
Ascend Wellness Holdings Revenue
In the year 2025, Ascend Wellness Holdings had annual revenue of $500.58M USD, down -10.87%. Ascend Wellness Holdings had revenue of $120.55M in the quarter ending December 31, 2025, a decrease of -11.37%.
Revenue
$500.58M
Revenue Growth
-10.87%
P/S Ratio
0.19
Revenue / Employee
$208.58K
Employees
2,400
Market Cap
133.19M CAD
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 500.58M | -61.02M | -10.87% |
| Dec 31, 2024 | 561.60M | 43.01M | 8.29% |
| Dec 31, 2023 | 518.59M | 112.66M | 27.75% |
| Dec 31, 2022 | 405.93M | 73.55M | 22.13% |
| Dec 31, 2021 | 332.38M | 188.65M | 131.25% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Organigram Global | 279.99M |
| Planet 13 Holdings | 151.05M |
| Auxly Cannabis Group | 146.00M |
| Medexus Pharmaceuticals | 136.34M |
| Cannara Biotech | 112.25M |
| HLS Therapeutics | 76.10M |
| Charlotte's Web Holdings | 68.58M |
| BioSyent | 42.18M |